An official website of the United States government

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2023
Affiliation
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: steven.coca@mssm.edu.; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.; Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennesse.; Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.; Division of Nephrology, Veterans Affairs New York Harbor Healthcare System and New York University School of Medicine, New York, New York.; Clinical and Biomedical Proteomics Group, Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.; Clinical and Biomedical Proteomics Group, Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.; Department of Renal Medicine, Royal Derby Hospital, Derby, United Kingdom.; Randox Teoranta, Donegal, Ireland.; Randox Laboratories Ltd, Crumlin, United Kingdom.; Randox Teoranta, Donegal, Ireland.; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.; Department of Renal Medicine, Royal Derby Hospital, Derby, United Kingdom; Centre for Kidney Research and Innovation, University of Nottingham, Nottingham, United Kingdom.; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland. Electronic address: chirag.parikh@jhmi.edu.
Authors
Coca Steven G, Vasquez-Rios George, Mansour Sherry G, Moledina Dennis G, Thiessen-Philbrook Heather, Wurfel Mark M, Bhatraju Pavan, Himmelfarb Jonathan, Siew Eddie, Garg Amit X, Hsu Chi-Yuan, Liu Kathleen D, Kimmel Paul L, Chinchilli Vernon M, Kaufman James S, Wilson Michelle, Banks Rosamonde E, Packington Rebecca, McCole Eibhlin, Kurth Mary Jo, Richardson Ciaran, Go Alan S, Selby Nicholas M, Parikh Chirag R
Studies

Abstract

The role of plasma soluble tumor necrosis factor receptor 1 (sTNFR1) and sTNFR2 in the prognosis of clinical events after hospitalization with or without acute kidney injury (AKI) is unknown.